BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11377175)

  • 1. Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists.
    Scapecchi S; Marucci G; Matucci R; Angeli P; Bellucci C; Buccioni M; Dei S; Gualtieri F; Manetti D; Romanelli MN; Teodori E
    Bioorg Med Chem; 2001 May; 9(5):1165-74. PubMed ID: 11377175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antimuscarinic activity of some ether- and thioether-bearing 1,3-dioxolanes and related sulfoxides and sulfones.
    Malmusi L; Franchini S; Mucci A; Schenetti L; Gulini U; Marucci G; Brasili L
    Bioorg Med Chem; 1998 Jun; 6(6):825-32. PubMed ID: 9681148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes.
    Barocelli E; Ballabeni V; Bertoni S; Dallanoce C; De Amici M; De Micheli C; Impicciatore M
    Life Sci; 2000 Jun; 67(6):717-23. PubMed ID: 12659177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
    Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine.
    Piergentili A; Gentili F; Ghelfi F; Marucci G; Pigini M; Quaglia W; Giannella M
    Bioorg Med Chem; 2003 Sep; 11(18):3901-11. PubMed ID: 12927850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
    Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
    Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
    Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
    Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?
    Eltze M; König H; Ullrich B; Grebe T
    Eur J Pharmacol; 1997 Jul; 332(1):77-87. PubMed ID: 9298928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
    Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
    Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo muscarinic cholinergic mediated effects of Lu 25-109, a M1 agonist and M2/M3 antagonist in vitro.
    Sánchez C; Arnt J; Didriksen M; Dragsted N; Moltzen Lenz S; Matz J
    Psychopharmacology (Berl); 1998 Jun; 137(3):233-40. PubMed ID: 9683000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of peripheral muscarinic subtypes in anesthetized cats.
    Koss MC
    Life Sci; 1997; 61(2):217-27. PubMed ID: 9217280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and muscarinic activities of 3-(pyrazolyl)-1,2,5,6-tetrahydropyridine derivatives.
    Plate R; Plaum MJ; de Boer T; Andrews JS; Rae DR; Gibson S
    Bioorg Med Chem; 1996 Feb; 4(2):227-37. PubMed ID: 8814880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M3/M1-Selective antimuscarinic tropinyl and piperidinyl esters.
    Xu R; Sim MK; Go ML
    Eur J Pharm Sci; 1999 Apr; 8(1):39-47. PubMed ID: 10072477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of methoctramine-related polyamines as muscarinic antagonist: effect of replacing the inner polymethylene chain with cyclic moieties.
    Tumiatti V; Minarini A; Milelli A; Rosini M; Buccioni M; Marucci G; Ghelardini C; Bellucci C; Melchiorre C
    Bioorg Med Chem; 2007 Mar; 15(6):2312-21. PubMed ID: 17276075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the interaction of zamifenacin at muscarinic receptors in vitro.
    Watson N; Reddy H; Stefanich E; Eglen RM
    Eur J Pharmacol; 1995 Oct; 285(2):135-42. PubMed ID: 8566131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.
    Angeli P; Marucci G; Buccioni M; Piergentili A; Giannella M; Quaglia W; Pigini M; Cantalamessa F; Nasuti C; Novi F; Maggio R; Qasem AR; Spampinato S
    Life Sci; 2002 Feb; 70(12):1427-46. PubMed ID: 11883718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
    Adachi S; Koike K; Takayanagi I
    Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.